Search Within

Benjamin Diamond

Formats
  1. Journal Article (14)
  2. Meeting Abstract (9)
  3. Review (7)
  4. Research Letter (3)
Groups
  1. Hematology-Oncology Fellows (33)
  2. Department of Medicine (31)
  3. Hematologic Malignancies, Division of (31)
  4. Center for Hematologic Malignancies (28)
  5. Myeloma (27)
  6. Hematologic Malignancies Research (25)

More Groups

People
  1. Carl Landgren (22)
  2. Malin Hultcrantz (21)
  3. Kylee Maclachlan (20)
  4. Francesco Maura (19)
  5. Ahmet Dogan (16)
  6. Even Rustad (15)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (14)
  4. 2020 (15)
  5. 2019 (1)
Publications
  1. Blood (9)
  2. Leukemia (4)
  3. Nature Communications (3)
  4. Best Practice and Research: Clinical Haematology (2)
  5. Blood Cancer Discovery (2)
  6. American Journal of Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. Nature Publishing Group (7)
  3. Elsevier Inc. (4)
  4. American Association for Cancer Research (3)
  5. Elsevier Science, Inc. (2)
  6. Royal College of Pathologists of Australasia (1)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Chromothripsis as a pathogenic driver of multiple myeloma
    Review

    Maura, F.; Boyle, E. M.; Rustad, E. H.; Ashby, C.; Kaminetzky, D.; Bruno, B.; Braunstein, M.; Bauer, M.; Blaney, P.; Wang, Y.; more...
    Seminars in Cell and Developmental Biology (2022)

    Fulltext@MSK | Save
  • Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
    Journal Article

    Boyle, E. M.; Williams, L.; Blaney, P.; Ashby, C.; Bauer, M.; Walker, B. A.; Ghamlouch, H.; Choi, J.; Perrial, E.; Wang, Y.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
    Journal Article

    Maclachlan, K. H.; Rustad, E. H.; Derkach, A.; Zheng-Lin, B.; Yellapantula, V.; Diamond, B.; Hultcrantz, M.; Ziccheddu, B.; Boyle, E. M.; Blaney, P.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • The mutagenic impact of melphalan in multiple myeloma
    Review

    Maura, F.; Weinhold, N.; Diamond, B.; Kazandjian, D.; Rasche, L.; Morgan, G.; Landgren, O.
    Leukemia (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma
    Journal Article

    Jonsdottir, G.; Björkholm, M.; Turesson, I.; Hultcrantz, M.; Diamond, B.; Porwit, A.; Landgren, O.; Kristinsson, S. Y.
    European Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Positive selection as the unifying force for clonal evolution in multiple myeloma
    Research Letter

    Diamond, B.; Yellapantula, V.; Rustad, E. H.; Maclachlan, K. H.; Mayerhoefer, M.; Kaiser, M.; Morgan, G.; Landgren, O.; Maura, F.
    Leukemia (2021)

    Fulltext@MSK | Save
  • Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Research Letter

    Korde, N.; Mastey, D.; Tavitian, E.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Shah, U.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save